Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Pulmonx Corp (NQ: LUNG )

6.780 -0.010 (-0.15%)
Streaming Delayed Price Updated: 2:42 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 138,114
Open 6.800
Bid (Size) 6.780 (2)
Ask (Size) 6.810 (6)
Prev. Close 6.790
Today's Range 6.610 - 7.090
52wk Range 5.460 - 14.84
Shares Outstanding 36,690,233
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers
From Pulmonx Corporation
Via Business Wire

Performance

YTD
-46.61%
-46.61%
1 Month
+12.44%
+12.44%
3 Month
-12.06%
-12.06%
6 Month
-15.36%
-15.36%
1 Year
-38.86%
-38.86%

More News

Read More
Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
From Pulmonx Corporation
Via GlobeNewswire
Earnings Preview For Pulmonx
Via Benzinga
Navigating 6 Analyst Ratings For Pulmonx
Via Benzinga
Pulmonx to Present at the Stifel 2024 Healthcare Conference
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx Reports Third Quarter 2024 Financial Results
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth Conference
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx to Present at the 2024 Wells Fargo Healthcare Conference
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx Reports Second Quarter 2024 Financial Results
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx to Present at the Canaccord Genuity 44th Annual Growth Conference
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024
From Pulmonx Corporation
Via GlobeNewswire
5 Medical Info Systems Stocks To Buy For Stable Returns
Via Talk Markets
Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Pulmonx Corporation
Via GlobeNewswire
C.H. Robinson Worldwide Posts Upbeat Results, Joins Avis Budget Group, Qualcomm, BorgWarner, Moderna And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
LUNG Stock Earnings: Pulmonx Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Pulmonx Reports First Quarter 2024 Financial Results
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal Trial
From Pulmonx Corporation
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.